ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DEPO Depomed, Inc. (delisted)

7.30
0.00 (0.00%)
06 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Depomed, Inc. (delisted) NASDAQ:DEPO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.30 7.25 7.43 0 01:00:00

Depomed to Present at Healthcare Conferences in February

08/02/2017 1:00pm

GlobeNewswire Inc.


Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Depomed, Inc. (delisted) Charts.

Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following healthcare conferences during the month of February.

LEERINK Partners 6th Annual Global Healthcare Conference

Date: Wednesday, February 15, 2017 Time: 3:30 p.m. EST Location: New York, New York

RBC Capital Markets 2017 Global Healthcare Conference

Date: Thursday, February 23, 2017 Time: 8:00 a.m. EST Location: New York, New York

The fireside chats will be webcast live and may be accessed via the Investor Relations page of the Depomed website at www.depomed.com.  A recording of these events will be archived for 30 days on the company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

 

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com

1 Year Depomed, Inc. (delisted) Chart

1 Year Depomed, Inc. (delisted) Chart

1 Month Depomed, Inc. (delisted) Chart

1 Month Depomed, Inc. (delisted) Chart

Your Recent History

Delayed Upgrade Clock